NCT00109148View on ClinicalTrials.gov

An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

February 28, 2005

Conditions
Obesity
Interventions
DRUG

MK0364

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00109148 - An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006) | Biotech Hunter | Biotech Hunter